Genetic Testing in the Diagnosis and Biology of Acute Leukemia

American Journal of Clinical Pathology
Marian H HarrisMagdalena Czader

Abstract

The 2017 Workshop of the Society for Hematopathology/European Association for Haematopathology examined the role of molecular genetics in the diagnosis and biology of acute leukemia. Acute leukemias were reviewed in two sessions: "Genetic Testing in Diagnosis of Acute Leukemias" (53 cases) and "Genetics Revealing the Biology of Acute Leukemias" (41 cases). Cases included acute lymphoblastic leukemia, acute myeloid leukemia, and acute leukemia of ambiguous lineage. Many cases demonstrated genetic alterations of known diagnostic, prognostic, and/or therapeutic significance, while others exhibited alterations that illuminated disease biology. The workshop highlighted the complexity of acute leukemia diagnosis and follow-up, while illustrating advantages and pitfalls of molecular genetic testing. Our understanding of the molecular genetics of acute leukemias continues to grow rapidly. Awareness of the potential complexity of genetic architecture and environment is critical and emphasizes the importance of integrating clinical information with morphologic, immunophenotypic, and molecular genetic evaluation.

References

Jan 17, 2003·Leukemia·M L SmithJ Fitzgibbon
Nov 7, 2003·Leukemia·J W LeeS H Lee
Nov 1, 2006·Cancer Genetics and Cytogenetics·Pina D'AchilleLynda J Campbell
Jan 19, 2007·Haematologica·Thomas IllmerUNKNOWN DSIL2003 AML study group
Jan 9, 2009·The New England Journal of Medicine·Charles G MullighanUNKNOWN Children's Oncology Group
Jan 13, 2012·Nature·Jinghui ZhangCharles G Mullighan
Oct 16, 2012·Haematologica·Livio PaganoUNKNOWN GIMEMA-ALWP (Gruppo Italiano Malattie EMatologiche dell'Adulto, Acute Leukemia Working Party)
Aug 24, 2013·Clinical Lymphoma, Myeloma & Leukemia·Paolo StratiJorge Cortes
Mar 13, 2014·Cancer Genetics·Ji-Hun LimEul-Ju Seo
Sep 11, 2014·The New England Journal of Medicine·Kathryn G RobertsCharles G Mullighan
Jul 18, 2015·American Journal of Clinical Pathology·Magdalena Czader, Attilio Orazi
Oct 18, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Julia E MaxsonJeffrey W Tyner
Jun 9, 2016·The New England Journal of Medicine·Elli PapaemmanuilPeter J Campbell
Sep 15, 2016·Cancer Science·Akifumi EndoMasatoshi Takagi
Jan 21, 2017·Blood·Aleksandra Anna Łanocha, Barbara Zdziarska
Feb 10, 2017·Blood·Raman SoodPaul Liu
Mar 25, 2017·American Journal of Clinical Pathology·Matthew J OberleyMaurice R G O'Gorman
May 26, 2017·Leukemia & Lymphoma·Takumi HoshinoToru Sakura
May 26, 2017·BMC Cancer·Estelle MenuJean Gabert

❮ Previous
Next ❯

Citations

Jan 26, 2021·Evidence-based Complementary and Alternative Medicine : ECAM·Ricardo Ballesteros-RamírezSusana Fiorentino
Jul 27, 2021·Clinics in Laboratory Medicine·Marian H Harris
Aug 8, 2021·International Journal of Environmental Research and Public Health·Maja PtasiewiczRenata Chałas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.